The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 5,862,864 | 5,747,906 | SH | SOLE | 5,747,906 | 0 | 0 | |||
| AMERICAN WELL CORP | CL A | 03044L105 | 3,402,513 | 10,475,717 | SH | SOLE | 10,475,717 | 0 | 0 | |||
| ANNEXON INC | COM | 03589W102 | 36,289,518 | 7,406,024 | SH | SOLE | 7,406,024 | 0 | 0 | |||
| AADI BIOSCIENCE INC | COM | 00032Q104 | 2,381,012 | 1,630,830 | SH | SOLE | 1,630,830 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 3,079,980 | 213,000 | SH | SOLE | 213,000 | 0 | 0 | |||